Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 5, 2004, Pages 383-393

  Hawley, John A ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

GLUT4; Impaired glucose tolerance; Mitochondrial biogenesis; Obesity; Phosphatidylinositol 3 kinase; Physical activity; Type 2 diabetes

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE;

BODY MASS; DIET THERAPY; DISEASE PREDISPOSITION; EXERCISE; FATTY ACID METABOLISM; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MITOCHONDRIAL RESPIRATION; MOLECULAR MECHANICS; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MUSCLE, SKELETAL;

EID: 4644235275     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.505     Document Type: Review

References (181)

1. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 2002; 25: 829-834.
2. Warram. JH, Rich SS, Krolewski AS. Epidemiology and genetics of diabetes mellitus. In Joslin's Diabetes Mellitus, Kahn CR, Weir GC (eds). Lea and Febiger: Philadelphia, 1995.
3. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998; 21: 518-524.
4. American Diabetes Association. Diabetes 1996: Vital Statistics. American Diabetes Association: Alexandria, VA, 1996.
5. Pinhas-Hamiel O, Zeitler P. Insulin resistance, obesity, and related disorders among black adolescents. J Pediatr 1996; 129: 319-320.
6. Leibson CL, Williamson DF, Melton LJ. 3rd, et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001; 24: 1584-1589.
7. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362-2374.
8. Hu FB, Sigal RJ, Rich-Edwards JW, et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 1999; 282: 1433-1439.
9. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
10. Seals DR, Hagberg JM, Allen WK, et al. Glucose tolerance in young and older athletes and sedentary men. J Appl Physiol 1984; 56: 1521-1525.
11. Albright A, Franz M, Hornsby G, et al. American College of Sports Medicine Position stand: Exercise and type 2 diabetes. Med Sci Sports Exerc 2002; 32: 1345-1360.
12. Bloomgarden ZT. American Diabetes Association Annual Meeting, 1998. Insulin resistance, exercise, and obesity. Diabetes Care 1999; 22: 517-522.
13. Clark DO. Physical activity efficacy and effectiveness among older adults and minorities. Diabetes Care 1997; 20: 1176-1182.
14. Eriksson JG. Exercise and the treatment of type 2 diabetes mellitus. An update. Sports Med 1999; 27: 381-391.
15. Perez-Martin A, Raynaud E, Mercier J. Insulin resistance and associated metabolic abnormalities in muscle: effects of exercise. Obes Rev 2001; 2: 47-59.
16. Henriksen EJ. Invited review: Effects of acute exercise and exercise training on insulin resistance. J Appl Physiol 2002; 93: 788-796.
17. Ivy JL. Exercise training and muscle insulin resistance: Cellular adaptations. In Muscle Metabolism, Zierath J, Wallberg-Henriksson H (eds). Taylor and Francis: London, 2002; 349-364.
18. Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998; 9: 235-261.
19. Wojtaszewski JF, Hansen BF, Gade J, et al. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 2000; 49: 325-331.
20. West KM. Epidemiology of Diabetes and its Vascular Lesions. Elsevier: New York, 1978.
21. Kawate R, Yamakido M, Nishimoto Y, Bennett PH, Hamman RF, Knowler WC. Diabetes mellitus and its vascular complications in Japanese migrants on the Island of Hawaii. Diabetes Care 1979; 2: 161-170.
22. Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO. Effects of a traditional lifestyle on obesity in Pima Indians. Diabetes Care 1994; 17: 1067-1074.
23. Cruz-Vidal M, Costas R Jr, Garcia-Palmieri MR, Sorlie PD, Hertzmark E. Factors related to diabetes mellitus in Puerto Rican men. Diabetes 1979; 28: 300-307.
24. King H, Zimmet P, Raper LR, Balkau B. Risk factors for diabetes in three Pacific populations. Am J Epidemiol 1984; 119: 396-409.
25. Zimmet PZ, Faauiso S, Ainuu S, Whitehouse S, Milne B, Deboer W. The prevalence of diabetes in the rural and urban Polynesian population of Western Samoa. Diabetes 1981; 30: 45-51.
26. Dowse GK, Gareeboo H, Zimmet PZ, et al. High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes 1990; 39: 390-396.
27. Kriska AM, LaPorte RE, Pettitt DJ, et al. The association of physical activity with obesity, fat distribution and glucose intolerance in Pima Indians. Diabetologia 1993; 36: 863-869.
28. Taylor R, Ram P, Zimmet P, Raper LR, Ringrose H. Physical activity and prevalence of diabetes in Melanesian and Indian men in Fiji. Diabetologia 1984; 27: 578-582.
29. Cederholm J, Wibell L. Glucose tolerance and physical activity in a health survey of middle-aged subjects. Acta Med Scand 1985; 217: 373-378.
30. Lindgarde F, Saltin B. Daily physical activity, work capacity and glucose tolerance in lean and obese normoglycaemic middle-aged men. Diabetologia 1981; 20: 134-138.
31. Pereira MA, Kriska AM, Joswiak ML, et al. Physical inactivity and glucose intolerance in the multiethnic island of Mauritius. Med Sci Sports Exerc 1995; 27: 1626-1634.
32. Wang JT, Ho LT, Tang KT, Wang LM, Chen YD, Reaven GM. Effect of habitual physical activity on age-related glucose intolerance. J Am Geriatr Soc 1989; 37: 203-209.
33. Regensteiner JG, Shetterly SM, Mayer EJ, et al. Relationship between habitual physical activity and insulin area among individuals with impaired glucose tolerance. The San Luis Valley Diabetes Study. Diabetes Care 1995; 18: 490-497.
34. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE. Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol 2002; 93: 3-30.
35. Booth FW, Chakravarthy MV, Spangenburg EE. Exercise and gene expression: physiological regulation of the human genome through physical activity. J Physiol 2002; 543: 399-411.
36. Beaudet AL, Scriver CR, Sly WS, Valle D. Genetics, biochemistry, and molecular basis of variant human phenotypes. In The Metabolic'and Molecular Basis of Inherited Disease, (7th edn), vol. 1, Scriver CR, Beaudet AL, Sly WS, Valle D, Stanbury JB, Wyngaarden JB, Fredrickson DS (eds). McGraw Hill: New York, 1995; 79.
37. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
38. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991; 34: 891-898.
39. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
40. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
41. Kriska A. Can a physically active lifestyle prevent type 2 diabetes? Exerc Sport Sci Rev 2003; 31: 132-137.
42. Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindstrom J, Tuomilehto J. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish diabetes prevention study. Diabetes 2003; 52: 2532-2538.
43. Duncan GE, Perri MG, Theriaque DW, Hutson AD, Eckel RH, Stacpoole PW. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 2003; 26: 557-562.
44. Ivy JL, Zderic TW, Fogt DL. Prevention and treatment of noninsulin-dependent diabetes mellitus. Exerc Sport Sci Rev 1999; 27: 1-35.
45. Kriska AM, Pereira MA, Hanson RL, et al. Association of physical activity and serum insulin concentrations in two populations at high risk for type 2 diabetes but differing by BMI. Diabetes Care 2001; 24: 1175-1180.
46. Krook A, Holm I, Pettersson S, Wallberg-Henriksson H. Reduction of risk factors following lifestyle modification programme in subjects with type 2 (non-insulin dependent) diabetes mellitus. Clin Physiol Funct Imaging 2003; 23: 21-30.
47. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991; 338: 774-778.
48. Bogardus C, Lillioja S, Stone K, Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 1984; 73: 1185-1190.
49. Bonadonna RC, Del Prato S, Bonora E, et al. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 1996; 45: 915-925.
50. Hojlund K, Staehr P, Hansen BF, et al. Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 2003; 52: 1393-1402.
51. Kelley DE, Mokan M, Mandarino LJ. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 1992; 41: 698-706.
52. Mandarino LJ, Wright KS, Verity LS, et al. Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest 1987; 80: 655-663.
53. Pendergrass M, Koval J, Vogt C, et al. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. Diabetes 1998; 47: 387-394.
54. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223-228.
55. Michael MD, Kahn CR. Defects in early insulin signaling in skeletal muscle. In Muscle Metabolism, Zierath J, Wallberg-Henriksson H (eds). Taylor and Francis: London, 2002; 37-66.
56. Giorgina F. Defects in intermediate insulin signalling in skeletal muscle: Phosphatidylinositol (PI) 3-kinase and glucose transport. In Muscle Metabolism, Zierath J, Wallberg-Henriksson H (eds). Taylor and Francis: London, 2002; 67-86.
57. Zierath JR, Wallberg-Henriksson H. From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients. Ann N Y Acad Sci 2002; 967: 120-134.
58. Menzel S. Genetic and molecular analyses of complex metabolic disorders: genetic linkage. Ann N Y Acad Sci 2002; 967: 249-257.
59. Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann N Y Acad Sci 2002; 967: 146-157.
60. Bruce CR, Hawley JA. Improvements in insulin resistance with aerobic exercise training: a lipocentric approach. Med Sci Sports Exerc 2004; 36: 1196-1201.
61. Kraegen EW, Cooney GJ, Ye J, Thompson AL. Triglycerides, fatty acids and insulin resistance-hyperinsulinemia. Exp Clin Endocrinol Diabetes 2001; 109: S516-SS26.
62. Kraegen EW, Cooney GJ, Ye J, Thompson AL, Furler SM. Fatty acids and muscle insulin resistance. In Muscle Metabolism, Zierath JR, Wallberg-Henriksson (eds). Taylor and Francis: London, 2002; 37-66.
63. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51: 7-18.
64. Saltin B, Rowell LB. Functional adaptations to physical activity and inactivity. Fed Proc 1980; 39: 1506-1513.
65. Mikines KJ, Sonne B, Tronier B, Galbo H. Effects of training and detraining on dose-response relationship between glucose and insulin secretion. Am J Physiol 1989; 256: E588-E596.
66. Vukovich MD, Arciero PJ, Kohrt WM, Racette SB, Hansen PA, Holloszy JO. Changes in insulin action and GLUT-4 with 6 days of inactivity in endurance runners. J Appl Physiol 1996; 80: 240-244.
67. Saltin B. Metabolic fundamentals in exercise. Med Sci Sports 1973; 5: 137-146.
68. Katoh J, Hara Y, Kurusu M, Miyaji J, Narutaki K. Cardiorespiratory function as assessed by exercise testing in patients with non-insulin-dependent diabetes mellitus. J Int Med Res 1996; 24: 209-213.
69. Regensteiner JG, Bauer TA, Reusch JE, et al. Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus. J Appl Physiol 1998; 85: 310-317.
70. Regensteiner JG, Sippel J, McFarling ET, Wolfel EE, Hiatt WR. Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise. Med Sci Sports Exerc 1995; 27: 875-881.
71. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944-2950.
72. Duchen MR. Roles of mitochondria in health and disease. Diabetes 2004; 53: S96-S102.
73. Peterson KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671.
74. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004; 53: 1412-1417.
75. Pette D, Hofer HW. The constant proportion enzyme group concept in the selection of reference enzymes in metabolism. Trends Enzyme Histochem Cytochem 1980; 73: 231-244.
76. Gollnick PD, Saltin B. Significance of skeletal muscle oxidative enzyme enhancement with endurance training. Clin Physiol 1982; 2: 1-12.
77. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997; 83: 166-171.
78. Bruce CR, Anderson MJ, Carey AL, et al. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrin Metab 2003; 88: 5444-5451.
79. Bruce CR, Carey AL, Hawley JA, Febbraio MA. Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Diabetes 2003; 52: 2338-2345.
80. Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996; 45: 113-126.
81. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
82. Attie AD, Kendziorski CM. PGC-1α at the crossroads of type 2 diabetes. Nat Genet 2003; 34: 244-245.
83. Patti ME, Butte AJ, Crunkhorn S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci 2003; 100: 8466-8471.
84. Booth FW, Baldwin KM. Muscle plasticity: energy demanding and supply processes. In Handbook of Physiology, Section 12,Exercise Regulation and Integration of Multiple Systems, Rowell LB, Shepherd JT (eds). Oxford University Press: New York, 1997; 1075-1123.
85. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967; 242: 2278-2282.
86. Oscai LB, Holloszy JO. Biochemical adaptations in muscle. II. Response of mitochondrial adenosine triphosphatase, creatine phosphokinase, and adenylate kinase activities in skeletal muscle to exercise. J Biol Chem 1971; 246: 6968-6972.
87. Holloszy JO, Oscai LB, Don IJ, Mole PA. Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise. Biochem Biophys Res Commun 1970; 40: 1368-1373.
88. Mole PA, Oscai LB, Holloszy JO. Adaptation of muscle to exercise. Increase in levels of palmityl Coa synthetase, carnitine palmityltransferase, and palmityl CoA dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest 1971; 50: 2323-2330.
89. Yan Z, Salmons S, Jarvis J, Booth FW. Increased muscle carnitine palmitoyltransferase II mRNA after increased contractile activity. Am J Physiol 1995; 268: E277-E281.
90. Booth FW, Thomason DB. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 1991; 71: 541-585.
91. Fluck M, Hoppeler H. Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev Physiol Biochem Pharmacol 2003; 146: 159-216.
92. Hawley JA. Adaptations of skeletal muscle to prolonged, intense endurance training. Clin Exp Pharmacol Physiol 2002; 29: 218-222.
93. Hawley JA, Zierath JR. Integration of metabolic and mitogenic signal transduction in skeletal muscle. Exerc Sport Sci Rev 2004; 32: 4-8.
94. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 1984; 56: 831-838.
95. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981; 30: 1000-1007.
96. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985; 76: 149-155.
97. Eriksson J, Koranyi L, Bourey R, et al. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia 1992; 35: 143-147.
98. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223-228.
99. Henriksen JE, Alford F, Handberg A, et al. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest 1994; 94: 1196-1204.
100. Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991; 70: 1593-1600.
101. Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol 1997; 273: E1039-E1051.
102. Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci 1995; 92: 5817-5821.
103. Richter EA, Garetto LP, Goodman MN, Ruderman NB. Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J Clin Invest 1982; 69: 785-793.
104. Richter EA, Garetto LP, Goodman MN, Ruderman NB. Enhanced muscle glucose metabolism after exercise: modulation by local factors. Am J Physiol 1984; 246: E476-E482.
105. Wallberg-Henriksson H. Glucose transport into skeletal muscle. Influence of contractile activity, insulin, catecholamines and diabetes mellitus. Acta Physiol Scand (Suppl) 1987; 564: 1-80.
106. Wallberg-Henriksson H, Holloszy JO. Activation of glucose transport in diabetic muscle: responses to contraction and insulin. Am J Physiol 1985; 249: C233-C237.
107. Zierath JR. In vitro studies of human skeletal muscle: hormonal and metabolic regulation of glucose transport. Acta Physiol Scand (Suppl) 1995; 626: 1-96.
108. Zierath JR, Tsao TS, Stenbit AE, Ryder JW, Galuska D, Charron MJ. Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem 1998; 273: 20 910-20 915.
109. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14: 4902-4911.
110. Dorrestijn J, Ouwens DM, Van den Berghe N, Bos JL, Maassen JA. Expression of a dominant-negative Ras mutant does not affect stimulation of glucose uptake and glycogen synthesis by insulin. Diabetologia 1996; 39: 558-563.
111. Kanai F, Ito K, Todaka M, et al. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem Biophys Res Commun 1993; 195: 762-768.
112. Lee AD, Hansen PA, Holloszy JO. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 1995; 361: 51-54.
113. Goodyear LJ. AMP-activated protein kinase: a critical signaling intermediary for exercise-stimulated glucose transport? Exerc Sport Sci Rev 2000; 28: 113-116.
114. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47: 1369-1373.
115. Vavvas D, Apazidis A, Saha AK, et al. Contraction-induced changes in acetyl-CoA catboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 1997; 272: 13255-13261.
116. Bak JF, Jacobsen UK, Jorgensen FS, Pedersen O. Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training. J Clin Endocrinol Metab 1989; 69: 158-164.
117. Björnholm M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in skeletal muscle from NIDDM subjects following in vivo insulin stimulation. Diabetes 1997; 46: 524-527.
118. Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signalling in human muscle. J Clin Invest 2000; 105: 311-320.
119. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195-2204.
120. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 1999; 104: 733-741.
121. Krook A, Björnhohn M, Galuska D, et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 284-292.
122. Maegawa H, Shigeta Y, Egawa K, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991; 40: 815-819.
123. Nyomba BL, Ossowski VM, Bogardus C, Mott DM. Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Am J Physiol 1990; 258: E964-E974.
124. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 1998; 47: 1281-1286.
125. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-336.
126. Koistinen HA, Chibalin AV, Zierath JR. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia 2003; 46: 1324-1328.
127. Houmard JA, Shaw CD, Hickey MS, Tanner CJ. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle. Am J Physiol 1999; 277: E1055-E1060.
128. King DS, Dalsky GP, Staten MA, Clutter WE, Van Houten DR, Holloszy JO. Insulin action and secretion in endurance-trained and untrained humans. J Appl Physiol 1987; 63: 2247-2252.
129. Rodnick KJ, Haskell WL, Swislocki AL, Foley JE, Reaven GM. Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects. Am J Physiol 1987; 253: E489-E495.
130. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EE, Chisholm DJ. Changes in Aerobic Capacity and Visceral Fat but not Myocyte Lipid Levels Predict Increased Insulin Action After Exercise in Overweight and Obese Men. Diabetes Care 2003; 26: 1706-1713.
131. Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 2003; 52: 2191-2197.
132. Hickey MS, Gavigan KE, McCammon MR, et al. Effects of 7 days of exercise training on insulin action in morbidly obese men. J Clin Exerc Physiol 1999; 1: 24-28.
133. Devlin JT, Hirshman M, Horton ED, Horton ES. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 1987; 36: 434-439.
134. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Evans WJ. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol Endocrin Metab 1993; 264: E855-E862.
135. Rodgers MA, Yamamoto C, King DS, Hagberg JM, Eshani AA, Holloszy JO. Improvements in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 1988; 11: 613-618.
136. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA. Dissociation of muscle triglyceride content and insulin action after exercise training in patients with type 2 diabetes. Diabetolgia 2004; 47: 23-30.
137. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training. Diabetes 1995; 44: 1010-1020.
138. Kang J, Robertson RJ, Hagberg JM, et al. Effect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients. Diabetes Care 1996; 19: 341-349.
139. Poirier P, Tremblay A, Broderick T, Catellier C, Tancrede G, Nadeau A. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects?. Med Sci Monit 2002; 8: CR59-CR65.
140. Schneider S, Amorosa L, Khachadurian A, Ruderman N. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984; 26: 355-360.
141. Trovati M, Carta Q, Cavalot F, et al. Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 1984; 7: 416-420.
142. Blair SN, Kohl HW, Gordon NF, Paffenbarger RS Jr. How much physical activity is good for health?. Annu Rev Public Health 1992; 13: 99-126.
143. Fletcher GF, Blair SN, Blumenthal J, et al. Statement on exercise. Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart association. Circulation 1992; 86: 340-344.
144. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KM. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med 2003; 163: 1440-1447.
145. Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE. The effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol 2004; 96: 101-106.
146. Dohm GL. Invited review: Regulation of skeletal muscle GLUT-4 expression by exercise. J Appl Physiol 2002; 93: 782-787.
147. Zierath JR. Invited review: Exercise training-induced changes in insulin signalling in skeletal muscle. J Appl Physiol 2002; 93: 773-781.
148. Charron MJ, Katz EB, Zierath JR. Metabolic and molecular consequences of modifying GLUT4 expression in skeletal muscle. Biochem Soc Trans 1997; 25: 963-968.
149. Hood DA. Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 2001; 90: 1137-1157.
150. Hood DA, Takahashi M, Connor MK, Freyssenet D. Assembly of the cellular powerhouse: current issues in muscle mitochondrial biogenesis. Exerc Sport Sci Rev 2000; 28: 68-73.
151. Irrcher I, Adhihetty PJ, Joseph AM, Ljubicic V, Hood DA. Regulation of mitochondrial biogenesis in muscle by endurance exercise. Sports Med 2003; 33: 783-793.
152. Friedman JE, Sherman WM, Reed MJ, Elton CW, Dohm GL. Exercise training increases glucose transporter protein GLUT-4 in skeletal muscle of obese Zucker (fa/fa) rats. FEBS Lett 1990; 268: 13-16.
153. MacLean PS, Zheng D, Dohm GL. Muscle glucose transporter (GLUT 4) gene expression during exercise. Exerc Sport Sci Rev 2000; 28: 148-152.
154. Ren JM, Semenkovich CF, Gulve EA, Gao J, Holloszy JO. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem 1994; 269: 14 396-14 401.
155. Henriksen EJ, Bourey RE, Rodnick KJ, Koranyi L, Permutt MA, Holloszy JO. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol 1990; 259: E593-E598.
156. Kern M, Wells JA, Stephens JM, et al. Insulin responsiveness in skeletal muscle is determined by glucose transporter (GLUT 4) protein level. Biochem J 1990; 270: 397-400.
157. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000; 106: 847-856.
158. Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98: 115-124.
159. Baar K, Wende AR, Jones TE, et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 2002; 16: 1879-1886.
160. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 1992; 41: 465-475.
161. Pedersen O, Bak JF, Andersen PH, et al. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990; 39: 865-870.
162. Dela F, Ploug T, Handberg A, et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 1994; 43: 862-865.
163. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998; 101: 2377-2386.
164. Koistinen HA, Galuska D, Chibalin AV, et al. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 2003; 52: 1066-1072.
165. Ryder JW, Yang J, Galuska D, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647-654.
166. Kirwan JP, Jing M. Modulation of insulin signaling in human skeletal muscle in response to exercise. Exerc Sport Sci Rev 2002; 30: 85-90.
167. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3-10.
168. Cortight RN, Muoio DM, Dohm GL. Skeletal muscle lipid metabolism: a frontier for new insights into fuel homeostasis. Nutr Biochem 1997; 8: 228-245.
169. Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001; 24: 588-597.
170. Hurley BF, Nemeth PM, Martin WH, Hagberg JM, Dalsky GP, Holloszy JO. Muscle triglyceride utilization during exercise: effect of training. J Appl Physiol 1986; 60: 562-567.
171. Kiens B, Essen-Gustavsson B, Christensen NJ, Saltin B. Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training. J Physiol 1993; 469: 459-478.
172. Turcotte LP, Richter EA, Kiens B. Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs. untrained humans. Am J Physiol Endocrinol Metab 1992; 262: E791-E799.
173. Kiens B, Kristiansen S, Jensen P, Richter EA, Turcotte LP. Membrane associated fatty acid binding protein (FABPpm) in human skeletal muscle is increased by endurance training. Biochem Biophys Res Commun 1997; 231: 463-465.
174. Tunstall RJ, Mehan KA, Wadley GD, et al. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 2002; 283: E66-E72.
175. Coort SLM, Hasselbaink DM, Koonen DPY, et al. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats. Diabetes 2004; 53: 1655-1663.
176. Yki-Järvinen H, Helve E, Koivisto V. Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes 1987; 36: 892-896.
177. Helge JW, Dela F. Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity?. Diabetes 2003; 52: 1881-1887.
178. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes 2002; 51: 2005-2011.
179. Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci 2002; 967: 196-207.
180. Russell AP, Feilchenfeldt J, Schreiber S, et al. Endurance Training in Humans Leads to Fiber Type-Specific Increases in Levels of Peroxisome Proliferator-Activated Receptor-gamma Coactivator-1 and Peroxisome Proliferator-Activated Receptor-alpha in Skeletal Muscle. Diabetes 2003; 52: 2874-2881.
181. Short KR, Vittone JL, Bigelow ML, et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003; 52: 1888-1896.